HTGM - HTG Molecular Diagnostics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
21,434
21,504
14,760
5,133
4,042
Cost of Revenue
7,057
5,090
4,972
4,136
3,336
Gross Profit
14,377
16,413
9,788
997
706
Operating Expenses
Research Development
12,578
12,598
9,997
7,900
4,602
Selling General and Administrative
18,694
19,975
17,514
17,428
14,994
Total Operating Expenses
31,272
32,573
27,510
25,328
19,596
Operating Income or Loss
-16,895
-16,159
-17,723
-24,331
-18,890
Interest Expense
959
902
1,308
1,867
1,719
Total Other Income/Expenses Net
-
-105
0
57
-864
Income Before Tax
-17,133
-16,450
-18,957
-26,029
-21,388
Income Tax Expense
7
4
3
10
10
Income from Continuing Operations
-17,139
-16,454
-18,960
-26,040
-21,398
Net Income
-17,139
-16,454
-18,960
-26,040
-21,398
Net Income available to common shareholders
-17,139
-16,454
-18,960
-26,040
-22,726
Reported EPS
Basic
-
-0.60
-1.79
-3.66
-5.03
Diluted
-
-0.60
-1.79
-3.66
-5.03
Weighted average shares outstanding
Basic
-
27,523
10,597
7,113
4,518
Diluted
-
27,523
10,597
7,113
4,518
EBITDA
-
-14,080
-16,408
-22,688
-18,890